3rd FDA Panelist Resigns Over Approval of Alzheimer’s Drug

0
4

Another member of the Food and Drug Administration’s advisory panel resigned and called this week’s approval of an Alzheimer’s drug “probably the worst drug approval decision in recent U.S. history.” Harvard’s Aaron Kesselheim made the claim as the third expert advisory…

More

Source: NewsMax

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments